Medicaid Prescription-Drug Pricing Model Takes Shape

All states applied to a new Medicaid prescription-drug pricing model, with a September 30 participation deadline and projected savings of $64.3 billion. Beneficiary and pharmacy effects remain uncertain until states finalize participation, covered medicines, agreements, and implementation rules.